HMDB0002451 | 7b,12a-Dihydroxycholanoic acid | 84413-81-0 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0002488 | 7a,12b-dihydroxy-5b-Cholan-24-oic acid | 84413-82-1 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0002492 | 7a-Hydroxy-5b-cholanic acid | 28083-34-3 | | C24H40O3 | 376.5726 376.297745146 | Not Available |
HMDB0002497 | Glycochenodeoxycholate-3-sulfate | 67030-54-0 | | C26H43NO8S | 529.687 529.270938047 | Not Available |
HMDB0002504 | 3-Sulfodeoxycholic acid | 67030-48-2 | | C23H38O7S | 458.609 458.23382426 | Not Available |
HMDB0002522 | Chenodeoxycholic acid sulfate | 59132-31-9 | | C24H40O7S | 472.635 472.249474324 | Not Available |
HMDB0002536 | Isodeoxycholic acid | 566-17-6 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0002585 | 3beta,12beta-Dihydroxy-5beta-cholanoic acid | 84848-09-9 | | C24H40O4 | 392.572 392.292659768 | Not Available |
HMDB0002586 | Chenodeoxycholic acid 3-sulfate | 59132-32-0 | | C24H40O7S | 472.635 472.249474324 | Not Available |
HMDB0002642 | Ursodeoxycholic acid 3-sulfate | 68780-73-4 | | C24H40O7S | 472.635 472.249474324 | Not Available |
HMDB0006898 | Chenodeoxyglycocholic acid | | | C26H43NO5 | 449.6233 449.314123491 | Not Available |
HMDB0013866 | N-Desmethyltamoxifen | 31750-48-8 | | C25H27NO | 357.488 357.209264491 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0013961 | O-Desmethylverapamil (D-702) | | | C26H36N2O4 | 440.575 440.26750765 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0014351 | Reserpine | 50-55-5 | | C33H40N2O9 | 608.6787 608.273380888 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
- Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD: Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol. 2000 Jan;57(1):24-35. [PubMed:10617675 ]
|
HMDB0014620 | Chlorpromazine | 50-53-3 | | C17H19ClN2S | 318.864 318.095747015 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0014644 | Cimetidine | 51481-61-9 | | C10H16N6S | 252.339 252.115715232 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0014681 | Vincristine | 57-22-7 | | C46H56N4O10 | 824.9576 824.399644032 | - Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD: Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol. 2000 Jan;57(1):24-35. [PubMed:10617675 ]
|
HMDB0014699 | Bosentan | 147536-97-8 | | C27H29N5O6S | 551.614 551.183854375 | - Fattinger K, Funk C, Pantze M, Weber C, Reichen J, Stieger B, Meier PJ: The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions. Clin Pharmacol Ther. 2001 Apr;69(4):223-31. [PubMed:11309550 ]
|
HMDB0014710 | Vinblastine | 865-21-4 | | C46H58N4O9 | 810.9741 810.420379474 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
- Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD: Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol. 2000 Jan;57(1):24-35. [PubMed:10617675 ]
|
HMDB0014831 | Fluorescein | 2321-07-5 | | C20H12O5 | 332.3063 332.068473494 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0014832 | Daunorubicin | 20830-81-3 | | C27H29NO10 | 527.5199 527.179146153 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
- Lecureur V, Sun D, Hargrove P, Schuetz EG, Kim RB, Lan LB, Schuetz JD: Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein. Mol Pharmacol. 2000 Jan;57(1):24-35. [PubMed:10617675 ]
|
HMDB0014983 | Clofazimine | 2030-63-9 | | C27H22Cl2N4 | 473.396 472.122152138 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0015044 | Quinidine | 56-54-2 | | C20H24N2O2 | 324.4168 324.183778022 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0015132 | Doxorubicin | 23214-92-8 | | C27H29NO11 | 543.5193 543.174060775 | - Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
|
HMDB0015151 | Glyburide | 10238-21-8 | | C23H28ClN3O5S | 494.004 493.143819418 | - Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ: Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology. 2000 Feb;118(2):422-30. [PubMed:10648470 ]
- Wang EJ, Casciano CN, Clement RP, Johnson WW: Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. Pharm Res. 2003 Apr;20(4):537-44. [PubMed:12739759 ]
- Byrne JA, Strautnieks SS, Mieli-Vergani G, Higgins CF, Linton KJ, Thompson RJ: The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology. 2002 Nov;123(5):1649-58. [PubMed:12404239 ]
- Kemp DC, Brouwer KL: Viability assessment in sandwich-cultured rat hepatocytes after xenobiotic exposure. Toxicol In Vitro. 2004 Dec;18(6):869-77. [PubMed:15465654 ]
- Horikawa M, Kato Y, Tyson CA, Sugiyama Y: Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharmacokinet. 2003;18(1):16-22. [PubMed:15618715 ]
- Noe J, Hagenbuch B, Meier PJ, St-Pierre MV: Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatology. 2001 May;33(5):1223-31. [PubMed:11343252 ]
- Funk C, Pantze M, Jehle L, Ponelle C, Scheuermann G, Lazendic M, Gasser R: Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate. Toxicology. 2001 Oct 5;167(1):83-98. [PubMed:11557132 ]
|